Abstract
Somatic mutations can cause cancer and have recently been linked with a range of non-malignant diseases. Multistage models can characterise how mutations lead to cancer, and may also be applicable to these other diseases. Here we found the incidence of over 60% of common diseases in UK Biobank were consistent with a multistage model with an ordered sequence of stages, as approximated by a Weibull distribution, with the log of incidence linearly related to the log of age and the slope often interpreted as the number of stages. A model where the stages can occur in any order was also explored, as was stratification by smoking and diabetes status. Most importantly, we find that many diseases are low risk when young but then become inevitable in old age, but many other diseases do not, being more sporadic with a modest and modifiable risk that slowly increases with age.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Anthony Webster is supported by an intermediate research fellowship from the Nuffield Department of Population Health (NDPH). Robert Clarke is supported through core funding for NDPH from the Medical Research Council (MRC) and the British Heart Foundation (BHF). The University of Oxford MRC Population Health Research Unit is funded through a strategic partnership between the Medical Research Council and the University of Oxford.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
UK Biobank data can be accessed by application through www.ukbiobank.ac.uk, and summary data produced during this study will become available from OSF after peer review is complete.
